| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Announcement and Resource |
In the article "Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial" by G. Schernthaner, D. R. Matthews, B. Charbonnel, M. Hanefeld, P. Brunetti on Behalf of the QUARTET Study Group (The Journal of Clinical Endocrinology & Metabolism 89:60686076, 2004), the name of the study group was incorrectly listed as the QUARTER Study Group. The correct name is the QUARTET Study Group. The printer regrets the error.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |